Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
Author:
Affiliation:
1. Department of Ophthalmology and Visual Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan
Publisher
Informa UK Limited
Subject
Ophthalmology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/09273948.2020.1857791
Reference46 articles.
1. The natural history of uveitis
2. Uveitis and systemic disease.
3. The possible impact of uveitis in blindness: a literature survey.
4. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis
5. Anti-TNF therapies in the management of acute and chronic uveitis
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Disease of the Year for 2023: Pediatric Uveitis;Ocular Immunology and Inflammation;2023-11-26
2. Dirençli non-enfeksiyöz üveitli erişkin hastalarda adalimumab tedavisinin etkinliği;Cukurova Medical Journal;2023-07-02
3. Incidence and pre/post-treatment risk factors of glaucoma in Vogt-Koyanagi-Harada disease;International Ophthalmology;2023-03-17
4. Comparing biologic options for the management of Behcet’s disease-related uveitis;Expert Review of Clinical Immunology;2023-02-15
5. Analysis of Therapeutic Response to Adalimumab in Behçet’s Uveitis by Ultra-Widefield Fluorescein Angiography;Annals of Optometry and Contact Lens;2022-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3